Category Archives: Oncology

Further publications on BRCA1/2 variants and their impact on transitioning

Disclaimer: I am not a doctor and this is not medical advice. Last year, I wrote about case studies of pathological BRCA1 and BRCA2 gene variants in trans people, and how clinicians take these mutations into account during transition treatment. … Continue reading

Posted in Endocrinology, Oncology, Surgery, Transgender medicine | Tagged , | Leave a comment

Update on case reports: Cyproterone acetate and meningioma in trans women

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Disclaimer: I am not a doctor, and this is not medical advice. Do not take any medication without appropriate medical supervision. Summary Cyproterone acetate (CPA) is commonly used as … Continue reading

Posted in Endocrinology, Oncology, Transgender medicine | Tagged , , | Leave a comment

Additional information on transition treatment for trans women with BRCA1 or BRCA2 mutations

I’ve previously covered existing research on hormone therapy for trans women who are at an increased risk of breast cancer due to BRCA1 or BRCA2 mutations. As transitioning with estrogen induces the growth of breast tissue just as in cis … Continue reading

Posted in Endocrinology, Health care, Oncology, Surgery, Transgender medicine | Tagged , | Leave a comment

Trans women with BRCA mutations: options for hormone therapy

The risk of breast cancer is a concern for trans women transitioning using estrogen and anti-androgens: they experience the growth of substantial breast tissue just as cis women do, and the use of estrogen could promote the growth of any … Continue reading

Posted in Endocrinology, Oncology, Trans youth, Transgender medicine | Tagged , , | 1 Comment

On our radar: Textured breast implants linked to anaplastic large-cell lymphoma

Breast augmentation is a procedure sought by a substantial number of trans women who medically transition: 11% of trans women respondents to the 2015 U.S. Trans Survey report undergoing the procedure, while another 40% state that they want it some … Continue reading

Posted in Health care, Oncology, Surgery, Transgender medicine | Tagged | Leave a comment